Alexza (NASDAQ:ALXA) New Drug Application unaccepted, AMN (NYSE:AHS) Reports...
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced on Friday its new drug application for Adasuve, a schizophrenic and bipolar disorder treatment, cannot be permitted by the US Food and Drug...
View ArticlePfizer (NYSE:PFE) Can Cure Rare and Deadly Child Cancers – MRK, NVS, BMY,...
Pfizer Inc. (NYSE:PFE)’s drug that has transformed cure for adult lung cancers caused by a gene fault is now saving children with toxic tumors. Pfizer’s Xalkori eradicated symptoms of malignancy in...
View ArticleGlaxoSmithKline (NYSE:GSK) Plans to Buy Additional Stock in Indian Unit –...
GlaxoSmithKline PLC (NYSE:GSK)has shown interest in purchasing a further stake of almost 31.8% in its Indian division, GlaxoSmithKline Consumer Healthcare Ltd. , at 3,900 rupees ($70.3) a share, the...
View ArticlePfizer Inc., (NYSE:PFE) Lowering Sales Force, Working on New Drugs – PFE,...
Pfizer Inc., (NYSE:PFE) the New York health-care specialized firm, would lower almost a fifth of its 3,000-member sales force for primary-care pharmaceuticals as an element of an ongoing cost-lowering...
View ArticleEmergent Biosolutions (NYSE:EBS) Issues FY 2012 Results; Revenue Misses...
Emergent BiosolutionsInc (NYSE:EBS) on Monday reported its preliminary fiscal year 2012 financial results, projecting revenues slightly lower than Wall Street analysts’ forecasts. Biopharmaceutical...
View ArticleIllumina Inc. (NASDAQ:ILMN) Down to Knees after Roche Offer Refused – ILMN,...
Illumina Inc. (NASDAQ:ILMN)plunged almost 8.5% in premarket session on Monday following Roche Holding AG Chairman Franz Humer reported in an interview that the firm does not intend to purchase the gene...
View ArticleHerbalife (NYSE:HLF) Symbolized as Compelling Buy below $70 – HLF, GMCR,...
On Friday DA Davison expert Timothy Ramey reported that Herbalife (NYSE:HLF)is a “compelling buy” at any price less than $70 per share, in spite of disapproval of the firm by hedge fund manager Bill...
View ArticleIsis Pharmaceuticals, Inc. (NASDAQ:ISIS) Updates Claim of a Healthy Pipeline
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) lately gave an update on its pipeline. Isis Pharmaclaims of a healthy pipeline. The firm thinks 5 of its pipeline candidates can get acceptance within the...
View ArticleIllumina (NASDAQ:ILMN) Declares Sharp Boost in Fiscal Fourth Quarter Profit...
Illumina, Inc (NASDAQ:ILMN) announced a sharp boost in fiscal Q4 profit on Monday after the sale of a business unit to Amgen, Inc (NASDAQ:AMGN). Genetic analysis Instrument Company booked a $48.6...
View ArticleSequenom, Inc. (NASDAQ:SQNM) Revenue Surges, Assured Guaranty Ltd. (NYSE:AGO)...
Sequenom, Inc. (NASDAQ:SQNM), a life sciences firm giving innovative genetic analysis solutions, on Thursday declared revenue of $38.5 million for the first quarter of this year, a hike of 158% in...
View Article
More Pages to Explore .....